注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Cytosorbents Corp是一家专注于重症监护的免疫治疗公司。该公司通过聚合物吸附技术进行血液净化,从事重症监护(ICU)和心脏手术中危及生命的疾病的治疗。该公司的主导产品CytoSorb是一种体外细胞因子吸收剂,旨在减少细胞因子风暴或细胞因子释放综合征,否则可能导致大量炎症、器官衰竭和常见危重疾病死亡,如败血症、烧伤、创伤、肺损伤、癌症免疫治疗和胰腺炎引起的细胞因子释放综合征。其其他产品包括动物靶向VetResQ、DrugSorb ATR和ECOS-300CY。该公司正在开发的候选产品包括CytoSorb XL、BetaSorb、Contrast Sorb、DrugSorb、HemoDefense RBC、HemoDefense BGA、K+Control,以及其他包含吸附剂和多孔聚合物珠的药筒。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Carl H. June | 69 | 2017 | Member of Scientific Advisory Board |
Jiny Kim | 46 | 2022 | Independent Director |
Peter Wearden | - | - | Member of Cardiac Surgery Advisory Board |
Phillip P. Chan | 53 | 2008 | CEO & Director |
Mitchell Cohen | - | - | Member of Trauma Advisory Board |
Ernest E. Moore | - | 2013 | Member of Trauma Advisory Board |
Michael G. Bator | 59 | 2015 | Independent Chairman of the Board |
Craig R. Smith | - | - | Member of Cardiac Surgery Advisory Board |
Joseph Zwischenberger | - | 2014 | Chairman of Cardiac Surgery Advisory Board |
Claudio Ronco | - | - | Member of Critical Care Advisory Board |
Alan D. Sobel | 62 | 2014 | Independent Director |
Robert H. Bartlett | 84 | 2009 | Co-Chairman of Cardiac Surgery Advisory Board & Consultant |
Edward R. Jones | 75 | 2007 | Independent Director |
Ronald V. Maier | - | 2013 | Chairman of the Trauma Advisory Board |
Joseph E. Parrillo | - | - | Member of Critical Care Advisory Board |
Jonathan William Haft | - | 2014 | Member of Cardiac Surgery Advisory Board |
Nicholas Smedira | - | 2014 | Member of Cardiac Surgery Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核